Correlation Between Acrivon Therapeutics, and Rani Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Acrivon Therapeutics, and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Rani Therapeutics.
Diversification Opportunities for Acrivon Therapeutics, and Rani Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acrivon and Rani is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Rani Therapeutics go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Rani Therapeutics
Given the investment horizon of 90 days Acrivon Therapeutics, is expected to generate 3.82 times less return on investment than Rani Therapeutics. But when comparing it to its historical volatility, Acrivon Therapeutics, Common is 1.0 times less risky than Rani Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 143.00 in Rani Therapeutics Holdings on November 28, 2024 and sell it today you would earn a total of 11.00 from holding Rani Therapeutics Holdings or generate 7.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Rani Therapeutics Holdings
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Rani Therapeutics |
Acrivon Therapeutics, and Rani Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Rani Therapeutics
The main advantage of trading using opposite Acrivon Therapeutics, and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |